Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy

NCT05303038 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer in the Liver

Interventions

COMBINATION_PRODUCT: Cryoablation Combined with Tirelizumab and Bevacizumab

Sponsor

Fudan University